Usana Health Sciences (USNA) Net Cash Flow (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Net Cash Flow data on file, last reported at $3.5 million in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 223.11% year-over-year to $3.5 million in Q2 2026; TTM through Apr 2026 was -$22.0 million, a 85.04% increase from a year earlier, with the FY2026 full-year figure at -$28.4 million, up 80.09% from the prior year.
• Net Cash Flow for Q2 2026 stood at $3.5 million, down from $11.2 million in the prior quarter.
• Over the last five years, Net Cash Flow for USNA reached as high as $37.0 million in Q4 2022 and fell as low as -$176.4 million in Q4 2024.
• Historically, Net Cash Flow has averaged -$9.8 million across 5 years, with a median of $4.3 million in 2024.
• Across the five-year window, Net Cash Flow jumped 1542.61% in 2023 and slumped 1011.32% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at $37.0 million in 2022, then sank by 47.72% to $19.4 million in 2023, then slumped by 1011.32% to -$176.4 million in 2024, then jumped by 96.52% to -$6.1 million in 2025, then surged by 157.36% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $3.5 million in Q2 2026, $11.2 million in Q1 2026, and -$6.1 million in Q3 2025.